You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Danaher
since
auto-detected in 12 stories
10 days ago
Danaher shares fell on the news that it was acquiring medtech player Masimo.
Danaher to buy Masimo in $9.9 billion deal in diagnostics push ⊕
The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.
Stocks making the biggest moves premarket: Warner Bros. Discovery, Paramount Skydance, Masimo, Danaher & more ○
found
These are the stocks posting the largest moves in early trading.
Danaher closes in on a nearly $10bn deal for med tech company Masimo ○
Device maker is in a long-running intellectual property dispute with Apple
30 days ago
Danaher stock fails to rise on solid earnings — leading us to question what's next ⊕
While the quarter was solid and 2026 is shaping up to be better than 2025, the progress has been slower than we would like.
74 days ago
Why Wall Street and Jim Cramer think Danaher stock is 'ready to go for a romp' ⊕
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does, too.
86 days ago
Jim Cramer has faith in Danaher's turnaround as life sciences comes back to life ⊕
Life sciences stocks are seeing a resurgence — and that's good news for Danaher.
3 months ago
Danaher stock may be turning the corner. What needs to happen to keep it that way ⊕
Danaher's rebound is generating optimism, but there's still work ahead for the company to hit is 2026 growth targets.
4 months ago
Danaher gives investors reasons to stick around, sending beaten-up shares flying ⊕
The supplier of tools to drugmakers and hospitals is set up for a stronger 2026.
7 months ago
Danaher's imperfect quarter is good enough for us to stay the course ○
Shares fluctuated between gains and losses in Tuesday's session.